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High incidence of spontaneous and chemically induced liver
tumors in mice deficient for connexin32
Achim Temme*, Albrecht Buchmann†, Heinz-Dieter Gabriel*, Eric Nelles*,
Michael Schwarz† and Klaus Willecke*
Connexins are subunits of gap junction channels, which
mediate the direct transfer of ions, second messenger
molecules and other metabolites between contacting
cells. Gap junctions are thought to be involved in tissue
homeostasis, embryonic development and the control of
cell proliferation [1,2]. It has also been suggested that
the loss of intercellular communication via gap junctions
may contribute to multistage carcinogenesis [3–5]. We
have previously shown that transgenic mice that lack
connexin32 (Cx32), the major gap junction protein
expressed in hepatocytes, express lower levels of a
second hepatic gap junction protein, Cx26, suggesting
that Cx32 has a stabilizing effect on Cx26 [6]. Here, we
report that male and female one-year-old mice deficient
for Cx32 had 25-fold more and 8-fold more spontaneous
liver tumors than wild-type mice, respectively.
Incorporation of bromodeoxyuridine (BrdU) into the liver
was higher for Cx32-deficient mice than for wild-type
mice, suggesting that their hepatocyte proliferation rate
was higher. Furthermore, intraperitoneal injection, two
weeks after birth, of the carcinogen diethylnitrosamine
(DEN) led, after one year, both to more liver tumors in
Cx32-deficient mice than in controls, and to accelerated
tumor growth. Loss of Cx32 protein from hepatic gap
junctions is therefore likely to cause enhanced clonal
survival and expansion of mutated (‘initiated’) cells,
which results in a higher susceptibility to hepatic tumors.
Our results demonstrate that functional gap junctions
inhibit the development of spontaneous and chemically
induced tumors in mouse liver.
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Results and discussion
Cx32-deficient mice are fertile and morphologically
normal, except that their average weight is 17% less than
wild-type controls [6]. We find here, however, that the
ratio of liver weight to body weight was very similar for
Cx32-deficient and wild-type mice (see supplementary
material). Nuclear labelling indices (LI) showed a 13.7-fold
higher incorporation of BrdU into hepatocytes of female
Cx32-deficient mice (LI: 0.110 ± 0.061%), and a 3.8-fold
higher incorporation into hepatocytes of male Cx32-defi-
cient mice (LI: 0.024 ± 0.006%), than into the correspond-
ing female (LI: 0.008 ± 0.005%; p < 0.05) and male (LI:
0.006 ± 0.003%; p < 0.05) wild-type hepatocytes. Addi-
tional analysis of the BrdU-labelled wild-type and Cx32-
deficient nuclei revealed no significant polyploidization, as
estimated by the average diameter of nuclei (data not
shown). As no increase was observed in either the poly-
ploidization of hepatocytes or the average weight of livers
from Cx32-deficient mice, and since strain-specific differ-
ences in the DNA precursor pool size between mutant and
wild-type mice are unlikely, our data suggest a higher cell
turnover in Cx32-deficient liver. This increased cell
turnover, which is larger in females than in males (presum-
ably as a result of the action of sex hormones) could lead to
aberrant cell proliferation and, therefore, to a higher proba-
bility of cells surviving tumor initiation.
After 12 months, Cx32-deficient male and female mice
had 25-fold more and 8-fold more spontaneous tumors per
liver than control mice, respectively. After 6 months,
macroscopically visible lesions were already detectable in
male Cx32-deficient mice, whereas the first tumors visible
in female Cx32-deficient mice, as well as male and female
wild-type mice, were present after 12 months (Table 1).
Intraperitoneal injection of DEN into 15-day-old mice
led, after 6 months, to a large increase in liver weight due
to massive tumor growth in Cx32-deficient mice, com-
pared to control mice (Figure 1a). DEN induces liver spe-
cific tumors as it is metabolically activated in hepatocytes
by abundant cytochrome P-450 isoenzymes leading to
alkylation of purine residues in DNA [7]. 
When we analyzed various organs other than liver that
express Cx32, such as pancreas, macroscopically visible
tumors were not detected. After 9 months, three-fold and
five-fold more macroscopically visible tumors were
counted in the livers of Cx32-deficient male and female
mice than in control animals, respectively (Figure 1b).
DEN-induced liver tumors appeared 3 months earlier in
male than in female mice, consistent with the known
effects of sex hormones on hepatocarcinogenesis in mice
[8]. Stereological analysis revealed that the fraction of liver
occupied by lesions deficient for the marker enzyme
glucose 6-phosphatase (G6Pase) was, on average, 62-fold
higher in Cx32-deficient male and female mice than in
wild-type animals (Figure 1c). The number of lesions
deficient for G6Pase, however, was only two-fold to three-
fold higher in Cx32-deficient mice, suggesting that the
Cx32 defect affected the proliferation of G6Pase-deficient
cells more than their initiation by the carcinogen. This
enhanced proliferation was clearly shown by the preferen-
tial shift with increasing time to larger diameters of DEN-
induced neoplastic areas in Cx32-deficient mice compared
to those in wild-type mice (see supplementary material).
Mice deficient for the Cx32 gene were generated by stan-
dard methods of targeted homologous recombination,
leading to a mixed genetic background of C57BL/6 and
129Sv inbred strains [6]. In order to expand the population
of Cx32-mutant mice, mice heterozygous for the Cx32
mutation were initially crossed with C57BL/6 mice, such
that Cx32-deficient mice have a higher C57BL/6 genetic
background than the C57BL/6/129/Sv-F1 controls [6].
Although the higher C57BL/6 genetic background should
have resulted in a decreased susceptibility to liver tumors
[9], the number and size of liver tumors were always found
to be dramatically higher in Cx32-deficient mice. We
therefore conclude that possible polymorphic differences
between the genetic background of the Cx32-deficient
and our wild-type controls (the F1 generation of a
C57BL/6 and 129Sv cross) are unlikely to have caused the
observed difference in tumorigenicity. 
The parenchymal origin of the liver tumors was confirmed
by northern blot hybridization, which showed that the
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Table 1
Spontaneous liver tumors in wild-type and Cx32-deficient mice.
Number of mice Average number 
Age of mice with at least one of tumors
Mice (months) tumor per liver per liver
Cx32 Y/+ 3 0/9 0
6 0/8 0
9 0/16 0
12 1/13 0.08 (± 0.06)
Cx32 Y/– 3 0/5 0
6 4/13 3.00 (± 1.89)
9 4/12 1.25 (± 0.46)*
12 12/21 2.00 (± 0.57)†
Cx32 +/+ 3 0/8 0
6 0/9 0
9 0/8 0
12 1/8 0.13 (± 0.18)
Cx32 –/– 3 0/7 0
6 0/13 0
9 0/12 0
12 7/17 1.12 (± 0.94)*
Cx32-deficient male (Cx32 Y/–) and female (Cx32 –/–) and wild-type
male (Cx32 Y/+) and female (Cx32 +/+) mice were sacrificed after 3,
6, 9, or 12 months and the livers were analyzed for macroscopically
visible tumors. The results were statistically significant when Cx32-
deficient mice were compared with the corresponding controls
(*p < 0.05 and †p < 0.01 using Wilcoxon’s test).
Figure 1
Graphs showing, for Cx32-deficient mice
(white circles and bars) and wild-type controls
(black circles and grey bars), (a) the increase
in liver weight of mice receiving a single
intraperitoneal injection of DEN 15 days after
birth, as a proportion of the mean liver weight
of untreated Cx32-deficient and wild-type
mice at each time point, (b) the numbers of
macroscopically visible liver tumors, and (c) a
quantitative evaluation of liver lesions deficient
for glucose 6-phosphatase (G6Pase). The
numbers of animals analyzed are indicated, as
are the results of statistical analysis using
Wilcoxon’ s test: *p < 0.05; †p < 0.01.
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tumors contained significant levels of albumin mRNA.
(Figure 2a). The relative amount of Cx26 mRNA was the
same in the tumors of Cx32-deficient mice as in corre-
sponding control livers, whereas tumors from wild-type
mice expressed, for unknown reasons, 40–50% less Cx26
mRNA than wild-type control livers (Figure 2a). Immuno-
fluorescence analysis of normal tissue confirmed that Cx26
expression was much lower in Cx32-deficient liver than in
wild-type liver (Figure 2d,e), as previously noted [6].
Interestingly, Cx26 protein expression was no lower in
Cx32-deficient liver tumors than in the surrounding
normal tissue (Figure 2e); there was also no impairment of
Cx32 and Cx26 protein expression in wild-type tumors
(Figure 2d,f). This contrasts with previous results using rat
liver, in which a tumor-specific decrease in Cx32 expres-
sion was observed [3].
Immunoblot analysis revealed that Cx26 protein expression
in Cx32-deficient liver was about two thirds lower than in
wild-type liver (Figure 2i). Cx32 apparently stabilizes the
Cx26 protein, possibly by heterotypic or heteromeric inter-
action when both proteins are subunits of the same gap
junction channel [10]. Thus, we cannot determine whether
the tumor suppressive effect of the intercellular communi-
cation mediated by gap junctions in mouse liver is due only
to the Cx32 protein itself or is augmented by functional
expression of the Cx26 protein. Liver tumors of male wild-
type mice expressed the same levels of Cx26 and Cx32
protein as control livers of wild-type mice (Figure 2h,i).
The level of Cx26 protein expression in tumors of Cx32-
deficient mice was slightly lower than in Cx32-deficient
control liver (Figure 2i). We do not know, however, to what
extent gap junction mediated intercellular communication
between neoplastic and surrounding normal cells (i.e. het-
erologous communication) was affected. It has previously
been shown that heterologous communication is dimin-
ished in rat liver carcinogenesis [11], possibly by phosphory-
lation of connexin proteins [2]. 
When we analyzed the cell-to-cell transfer of microinjected
Lucifer Yellow dye in Cx32-deficient primary embryonic
hepatocytes [12,13], we found that dye transfer was 60–70%
lower than in wild-type cells (see supplementary material).
Furthermore, total electrical conductance was more than
80% lower in Cx32-deficient cultured hepatocytes (V. Vali-
unas, H. Niessen, K.W. and R. Weingart, unpublished
observations). The residual intercellular dye transfer and
conductance among Cx32-deficient hepatocytes is likely to
be due to Cx26-containing gap junction channels. So why
does this residual gap junction communication not prevent
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(a) Northern blot hybridization of RNA from DEN-induced tumors and
control livers of male mice (labelled as in Table 1). G6Pase staining of
lesions from (b) wild-type and (c) Cx32-deficient mice; note the lack of
G6Pase activity in areas of neoplastic tissue. Indirect immunofluorescence
using antibodies specific for (d,e) Cx26 and (f,g) Cx32 on cryostat serial
sections from (d,f) wild-type and (e,g) Cx32-deficient liver. In Cx32-
deficient liver, (g) Cx32 expression was absent and (e) Cx26 protein
expression (arrowheads) was strongly decreased. The magnification bar is
50 µm. Immunoblot analysis, using (h) anti-Cx32 or (i) anti-Cx26
antibodies, of total protein from DEN-induced tumors and control livers of
male mice (labelled as in Table 1) or wild type liver, enriched for gap
junction plaques by alkali treatment [20]. (i) Note that, in addition to the
monomer, a dimer band at 37 kDa was recognized by Cx26 antibodies in
all samples that contained larger amounts of the Cx26 protein.
the increased hepatocarcinogenesis in Cx32-deficient mice?
We suggest that this may be primarily due to the different
permeabilities of Cx32 and Cx26 channels, described in
studies using several dyes [14]. Possibly, intercellular diffu-
sion of second messenger molecules such as cyclic
nucleotides or inositol 1,4,5-trisphosphate may be more
efficient through Cx32 channels than Cx26 channels. Loss
of Cx32 (and decreased expression of Cx26 protein) may
therefore cause an imbalance in metabolic cooperation or a
disturbed equilibration of second messenger molecules in
the liver acinus, which could result in enhanced prolifera-
tion of cells initiated to form tumors. 
Materials and methods
Treatment of animals and BrdU incorporation
Mice were kept under standard conditions and male and female off-
spring received on day 15 after birth a single intraperitoneal injection of
DEN (Sigma; 20 µg/g body weight), diluted with phosphate buffered
saline (PBS). DEN-treated and untreated Cx32-deficient mice as well
as C57BL/6/129/Sv-F1 controls [6] were weighed and sacrificed at 3,
6, 9 or 12 months. Whole mice were analyzed for macroscopically
visible tumors. All livers were excised, rinsed in PBS and weighed. Ran-
domly selected liver tumors were used for preparation of RNA and
protein. To assay the incorporation of BrdU, Cx32-deficient and wild-
type mice (6 months old), were injected intraperitoneally with BrdU
(200 µg/g body weight), 2 h and 4 h before sacrificing. The lobus sinis-
ter medialis was excised and stained for BrdU-positive nuclei, as
described [15]. For polyploidization analysis, the average diameters of
BrdU-labelled nuclei were measured. All data in this paper were statis-
tically evaluated, using Wilcoxon´s rank sum test for unpaired values.
Histochemistry, quantitative evaluation of tumors and indirect
immunofluorescence
For histochemical analysis, up to three sections (10 µm each) were
prepared from lobus sinister lateralis frozen on dry ice. The sections
were cut 200 µm apart from each other, in order to minimize double
counting of enzyme-altered lesions, and stained for G6Pase activity
[16]. Analysis of the volume fraction of enzyme-altered tissue in liver, as
well as the number and size distribution of enzyme-altered lesions,
were performed by the stereological procedure of Saltykov, as recom-
mended [17]. The immunochemical labelling procedure for Cx32 and
Cx26 protein has been described previously [18]. Primary antibodies
[monoclonal anti-rat Cx32 (0.5 µg/ml) and polyclonal rabbit anti-rat
Cx26 (1 µg/ml) both in 0.1% BSA] were provided by Zymed.
Preparation of RNA and northern blot analysis
Liver tumors ( > 1 mm in diameter) were excised and samples (10 µg)
of total RNA were subjected to agarose gel electrophoresis, blotted
onto Hybond-N membranes, hybridized to radiolabelled DNA probes
[12] and autoradiographed. Signals were normalized relative to the
amount of glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
mRNA [19].
Immunoblots
For protein analysis, samples were homogenized and sonificated [13].
Equal amounts of protein (50 µg) were subjected to polyacrylamide gel
electrophoresis: Cx26 was separated on a 10% gel, whereas Cx32
was separated on a 12.5% gel. Transfer of proteins onto nitrocellulose
and detection of Cx26 with antibodies (Zymed, 1.5 µg/ml) were per-
formed as previously described [13]. Equal amounts of total protein
and Cx32 immunoreactivity (Cx32 antibodies from Zymed, 1.5 µg/ml in
0.05 M Tris.HCl/0.15 M NaCl, pH 7.5) were monitored with the DIG
Total Protein/Antigen Double Staining Kit (mouse; Boehringer
Mannheim). Endogenous peroxidases or alkaline phosphatases were
blocked with 0.1% (w/v) Levamisole (Sigma) or 0.05% (v/v) H2O2
before incubating with antibodies. 
Supplementary material available
A table showing the liver weights and LI of hepatocytes and two figures
showing the diameters of DEN-induced neoplasia and dye transfer
among hepatocytes are published with this paper on the internet.
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